Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Proposed Study Entails a Follow-up of All the Completers for 2 Years With Visits Timed 3, 6, 12 and 24 Months After Completion of the 2-year CALERIE II Intervention.

NCT00943215 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.

NCT NCT00943215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00943215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Proposed Study Entails a Follow-up of All the Completers for 2 Years With Visits Timed 3, 6, 12 and 24 Months After Completion of the 2-year CALERIE II Intervention.
Lead sponsor
Pennington Biomedical Research Center
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
March 31, 2015
Enrollment
42 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

excessive diet restriction